Leda Mannent

8.1k total citations · 5 hit papers
74 papers, 2.6k citations indexed

About

Leda Mannent is a scholar working on Otorhinolaryngology, Immunology and Allergy and Physiology. According to data from OpenAlex, Leda Mannent has authored 74 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Otorhinolaryngology, 30 papers in Immunology and Allergy and 29 papers in Physiology. Recurrent topics in Leda Mannent's work include Sinusitis and nasal conditions (34 papers), Allergic Rhinitis and Sensitization (30 papers) and Asthma and respiratory diseases (29 papers). Leda Mannent is often cited by papers focused on Sinusitis and nasal conditions (34 papers), Allergic Rhinitis and Sensitization (30 papers) and Asthma and respiratory diseases (29 papers). Leda Mannent collaborates with scholars based in United States, France and Belgium. Leda Mannent's co-authors include Nikhil Amin, Joaquim Mullol, Claus Bachert, Neil M.H. Graham, Tanya M. Laidlaw, Peter W. Hellings, Gianluca Pirozzi, Jennifer D. Hamilton, Philippe Gevaert and Brian N. Swanson and has published in prestigious journals such as JAMA, Nature Medicine and Gastroenterology.

In The Last Decade

Leda Mannent

71 papers receiving 2.5k citations

Hit Papers

Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in... 2016 2026 2019 2022 2016 2020 2022 2023 2024 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis
    2016 553 citations Claus Bachert, Leda Mannent et al. profile →
  2. Chronic Rhinosinusitis with Nasal Polyps and Asthma
    2020 241 citations Tanya M. Laidlaw, Joaquim Mullol et al. The Journal of Allergy and Clinical Immunology In Practice profile →
  3. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis
    2022 146 citations Michael E. Wechsler, Faisal A. Khokhar et al. The Journal of Allergy and Clinical Immunology In Practice profile →
  4. Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
    2023 119 citations Gil Yosipovitch, Nicholas Mollanazar et al. Nature Medicine profile →
  5. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
    2024 65 citations Marcus Maurer, Thomas B. Casale et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leda Mannent United States 24 1.5k 1.4k 1.4k 657 406 74 2.6k
Ming Zheng China 16 565 0.4× 525 0.4× 599 0.4× 286 0.4× 55 0.1× 50 1.2k
Ian S. Mackay United Kingdom 15 714 0.5× 655 0.5× 394 0.3× 384 0.6× 30 0.1× 20 1.2k
J B Watelet Belgium 15 268 0.2× 423 0.3× 507 0.4× 349 0.5× 105 0.3× 43 1.0k
É. Serrano France 15 262 0.2× 315 0.2× 549 0.4× 432 0.7× 51 0.1× 48 997
Shinichi Haruna Japan 19 291 0.2× 301 0.2× 545 0.4× 386 0.6× 46 0.1× 74 892
Chih‐Feng Tai Taiwan 15 112 0.1× 156 0.1× 251 0.2× 254 0.4× 75 0.2× 40 695
Peter Olsson Sweden 17 179 0.1× 441 0.3× 15 0.0× 185 0.3× 152 0.4× 34 859
Gretchen M. Oakley United States 16 280 0.2× 190 0.1× 548 0.4× 526 0.8× 31 0.1× 43 873
David Weldon United States 11 474 0.3× 343 0.2× 7 0.0× 55 0.1× 736 1.8× 22 1.4k
Cengiz Özcan Türkiye 17 45 0.0× 128 0.1× 294 0.2× 413 0.6× 69 0.2× 74 952

Countries citing papers authored by Leda Mannent

Since Specialization
Citations

This map shows the geographic impact of Leda Mannent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leda Mannent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leda Mannent more than expected).

Fields of papers citing papers by Leda Mannent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leda Mannent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leda Mannent. The network helps show where Leda Mannent may publish in the future.

Co-authorship network of co-authors of Leda Mannent

This figure shows the co-authorship network connecting the top 25 collaborators of Leda Mannent. A scholar is included among the top collaborators of Leda Mannent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leda Mannent. Leda Mannent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giménez‐Arnau, Ana M., Silvia Mariel Ferrucci, Moshe Ben‐Shoshan, et al.. (2025). Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria. JAMA Dermatology. 161(7). 679–679. 6 indexed citations
2.
Busse, William W., Ian Pavord, Michael E. Wechsler, et al.. (2025). Reduction in the Use of Rescue Medication for Asthma Symptom Relief With Rilzabrutinib: Results from a Phase 2 Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1298–A1298. 1 indexed citations
3.
Bacharier, Leonard B., Ian Pavord, Jorge Máspero, et al.. (2024). Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma. Journal of Allergy and Clinical Immunology. 154(1). 101–110. 23 indexed citations
4.
Maurer, Marcus, Thomas B. Casale, Sarbjit S. Saini, et al.. (2024). Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials. Journal of Allergy and Clinical Immunology. 154(1). 184–194. 65 indexed citations breakdown →
5.
Simpson, Eric L., Jonathan I. Silverberg, Margitta Worm, et al.. (2023). 106 Dupilumab treatment in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial. Journal of Investigative Dermatology. 143(11). S350–S350. 1 indexed citations
6.
Chehade, Mirna, Evan S. Dellon, Jonathan M. Spergel, et al.. (2023). 605 DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS IN CHILDREN AGED 1-11 YEARS IN THE PHASE 3 EOE KIDS TRIAL. Gastroenterology. 164(6). S–112. 1 indexed citations
7.
Bachert, Claus, Tanya M. Laidlaw, Seong Cho, et al.. (2023). Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results. Annals of Otology Rhinology & Laryngology. 132(12). 1649–1661. 16 indexed citations
8.
Bredenoord, Albert J., Evan S. Dellon, Ikuo Hirano, et al.. (2023). 467 DUPILUMAB IMPROVES HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS, REGARDLESS OF PRIOR HISTORY OF ESOPHAGEAL DILATION. Gastroenterology. 164(6). S–90. 1 indexed citations
9.
Corren, Jonathan, Nicola A. Hanania, William W. Busse, et al.. (2023). Efficacy of dupilumab in patients with uncontrolled, moderate‐to‐severe asthma with fungal sensitization. Clinical & Experimental Allergy. 53(10). 1020–1030. 3 indexed citations
10.
Máspero, Jorge, Claus Bachert, Fernando J. Martínez, et al.. (2023). Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies. Journal of Asthma and Allergy. Volume 16. 333–342. 3 indexed citations
11.
Bacharier, Leonard B., Theresa W. Guilbert, Constance H. Katelaris, et al.. (2023). Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study. The Journal of Allergy and Clinical Immunology In Practice. 12(4). 948–959. 12 indexed citations
12.
Yosipovitch, Gil, Nicholas Mollanazar, Sonja Ständer, et al.. (2023). Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials. Nature Medicine. 29(5). 1180–1190. 119 indexed citations breakdown →
13.
Lee, Stella E., Claire Hopkins, Joaquim Mullol, et al.. (2022). Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies. Allergy. 77(7). 2211–2221. 40 indexed citations
14.
Papi, Alberto, Mario Castro, Jonathan Corren, et al.. (2021). LONG-TERM EFFECT OF DUPILUMAB ON LUNG FUNCTION IN PATIENTS WITH TYPE 2 ASTHMA: LIBERTY ASTHMA TRAVERSE STUDY. CHEST Journal. 160(4). A1854–A1858. 1 indexed citations
15.
Laidlaw, Tanya M., Claus Bachert, Nikhil Amin, et al.. (2021). Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma. Annals of Allergy Asthma & Immunology. 126(5). 584–592.e1. 75 indexed citations
16.
Khan, Asif, Adeline Abbé, Bruno Falissard, et al.. (2021). Data Mining of Free-Text Responses: An Innovative Approach to Analyzing Patient Perspectives on Treatment for Chronic Rhinosinusitis with Nasal Polyps in a Phase IIa Proof-of-Concept Study for Dupilumab. Patient Preference and Adherence. Volume 15. 2577–2586. 6 indexed citations
17.
Bansal, Ashish, Eric L. Simpson, Amy S. Paller, et al.. (2021). Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma. American Journal of Clinical Dermatology. 22(1). 101–115. 34 indexed citations
18.
Bachert, Claus, Peter W. Hellings, Joaquim Mullol, et al.. (2019). Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 75(1). 148–157. 74 indexed citations
19.
Bachert, Claus, S. James Zinreich, Peter W. Hellings, et al.. (2019). Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP. Rhinology Journal. 0(0). 0–0. 35 indexed citations
20.
Lee, Sangmi, Aaron Mattingly, Amity Lin, et al.. (2016). A novel antagonist of p75NTR reduces peripheral expansion and CNS trafficking of pro-inflammatory monocytes and spares function after traumatic brain injury. Journal of Neuroinflammation. 13(1). 88–88. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming Zheng Breakdown of academic impact, for papers by Ian S. Mackay Breakdown of academic impact, for papers by J B Watelet Breakdown of academic impact, for papers by É. Serrano Breakdown of academic impact, for papers by Shinichi Haruna Breakdown of academic impact, for papers by Chih‐Feng Tai Breakdown of academic impact, for papers by Peter Olsson Breakdown of academic impact, for papers by Gretchen M. Oakley Breakdown of academic impact, for papers by David Weldon Breakdown of academic impact, for papers by Cengiz Özcan
Rankless by CCL
2026